Human Experimentation: A Guided
Step into the Unknown WA Silverman pp 204 £20 ISBN 0-19-261499-1 Oxford University Press 1985 'Our scientific power has outrun our spiritual power. We have guided missiles and misguided men. ' So Wrote Martin Luther King in 1963, and William Silverman might have taken this aphorism as the text for this book. Dr Silverman is a distinguished American paediatrician, well known for his work on the association of retrolental fibroplasia with high concentrations of inspired oxygen in premature babies. He has produced a book which makes compelling reading, and follows Karl Popper in believing that the essence of science is its refutability: knowledge advances not from collecting observations, but from testing ideas. The book is dedicated to Richard L Day with the words 'He observed that a student is someone who thinks otherwise. And he taught that it is dangerous to treat this healthy state of mind'.
The book is largely about random controlled clinical trials. It is written in a pleasantly mid-Atlantic style and avoids parochialism (not unexpected from the Christensen Visiting Fellow of St Catherine's College, Oxford). He traces the evolution of the controlled trial from James Lind in 1753 (who treated 12 sailors suffering from scurvy in six ways and found that only the two given oranges and lemons were cured), through Karl Pearson in 1896 who invented the use of the word 'significant' to refer to the probable error of measurements, to Sir Ronald Fisher who, in 1925, introduced the concept of random allocation of treatments to subdivided plots of land. He pays tribute to Sir Austin Bradford Hill and the 1947 centrally-randomized trial of streptomycin in the treatment of pulmonary tuberculosis and to the (mainly American) workers who developed the science of non-parametric biostatistics. Throughout the book he repeatedly emphasizes that clinical research results in probabilities rather than in truths. This is particularly the case with the sort of epidemiological studies in which vast quantities of information are collected and the data dredged for 'significant' associations.
The justification for randomization in prospective clinical trials is the likelihood that bias will thereby be avoided. Dr Silverman points out in how many ways bias can still enter, and pleads for 'masking' (I prefer the word to 'blinding') of investigators, patients and assessors of events. Clinical trials enrol samples (and not random samples) of the population of diseased patients and the bias introduced by not recording the numbers (and fate) of excluded patients may vitiate the results of a trial. An uncontrolled pilot study can generate such enthusiasm for a new regimen that thousands of patients may undergo that treatment before a randomized study shows that the enthusiasm was unjustified; the lesson is that pilot studies should be randomized.
The ethics of human experimentation are briefly (in my own view, too briefly) discussed in the final chapter. WVhereas doctors will never advise treatment which they know to be inferior, and whereas no treatment will be carried out without the patient's consent, the question of asking consent to randomization remains a stumbling block and accounts for the slow rate of accrual to trials such as partial against total mastectomy for breast cancer. Dr
Silverman sidesteps this issue. The Declaration of Helsinki requires that patients shall be 'adequately informed of the aims, methods, anticipated benefits and potential hazards of the study and the discomfort it may entail'. Most patients, when they have been adequately informed, will say (or they will think it even if they do not say it) 'I came to you for your advice. What is your advice?' We must not overlook the possibility of the demise of the random controlled clinical trial in diseases in which the choice of treatment options is of great concern to patients. In these conditions, perhaps the best we can ask is complete and honest audit. I hope that the next edition will see Dr Silverman making the same thoughtful analysis of these problems as he has so manifestly done in the rest of the book. A V POLLOCK Consultant Surgeon Scarborough Hospital, North Yorkshire Molecular Biology of Host-Parasite Interactions N Agabian & H Eisen (ed) pp 351 £60 ISBN 0-8451-2612-1 New York: Alan R Liss 1984 Molecular biology of parasites is a fast growing discipline and no less than four books with similar titles have been issued within the last three years. This latest version includes a selection of 25 papers, 5 reviews and 4 workshop/poster session summaries from the first UCLA Symposium on the subject held in Park City in January-February 1983.
The table of contents is subdivided into five major topics: (1) parasite genomes, including papers on the structure of DNA and the regulation of antigen expression, all concerned with the variant surface antigen ofAfrican trypanosomes; (2) the biochemistry of parasite antigens and parasite metabolism; (3) the different mechanisms of parasite killing, including topics as varied as the effects of oxygen-dependent microbicidal mechanisms on different intracellular protozoa and the killing of Giardia lamblia by normal human milk, a hitherto undescribed mechanism of action (and probably the most original contribution to this book); (4) considerations on microbial pathogenesis, particularly the role of the binding of E. coli and shigella to epithelial cells, respectively in the urinary and intestinal tracts; and finally (5) the application of molecular tools to parasite taxonomy. The random organization of the papers in the book itself bears no relation to that of the table of contents.
The papers presented are all of a very high standard, but on average not very original (more than half have already been published in the same form elsewhere). Their collection in this glossy book, however, gives a vivid illustration of the state of research in molecular parasitology in 1983 and the book is undoubtedly the best of its kind at the moment. MARCEL HOMMEL Director, Wolfson Tropical Immunology Unit,
Liverpool School of Tropical Medicine
Mental Health and the Environment H Freeman (ed) pp 490 £40 ISBN 0-443-02780-3 Edinburgh: Churchill Livingstone 1985 Since Emile Durkheim pioneered the scientific study of the relationships between mental disorder and social factors, a large and growing volume of work on these associations has been carried out by workers in various disciplines, among them sociology, ecology,
